Iva

Iva Chianella, Bedfordshire GB

Patent application number	Description	Published
20090298194	BINDING DRUGS OF ABUSE - Drugs of abuse (e.g. cocaine) and related substances are selectively bound by an adsorbent which comprises units derived from carboxylic acids of formula A or B: (A): R	12-03-2009
20110111350	Conjugated Polymers - A monomer M-S has a first polymerisable moiety (M) capable of forming a conjugated polymer, and a second polymerisable moiety (S) with a double bond susceptible to addition polymerisation. Polymerisation of the M-moieties is caused, generally by electropolymerisation or chemical oxidation. Polymerisation of the S-moieties is also caused, generally by a radical mechanism, before, after or simultaneously with the M-polymerisation. Suitable monomers include N-(methacrylamidoethyl)-aniline, N-(acrylamidoethyl)-aniline, N-(methacryloyloxyethyl)-aniline and N-(acryloyloxyethyl)-aniline.	05-12-2011

Patent application number	Description	Published
20080311072	Preparation of Soluble and Colloidal Molecularly Imprinted Polymers by Living Polymerization - The present invention describes a method for synthesis of relatively low molecular weight imprinted polymers using living polymerization, and their application in analytical chemistry, pharmacology, medicine and the food industry. Specifically the low-molecular weight polymers are synthesized by the polymerization of functional monomers in the presence of a template, such as a biological receptor, enzyme, nucleic acid, cell, virus, microorganism, tissue sample or drug using living initiator. The conditions of living polymerization ensure a relatively small size of synthesized molecules. Synthesized in this way molecules (dimers, oligomers, polymers, or their mixture) have a higher affinity to the template than the original monomers and can rebind it in vitro and/or in vivo. As a further aspect of the present invention, polymers synthesized as described above can be used as drugs in pharmacology and medicine, as receptor-specific ligands in analytical chemistry (sensors, assays), and for separations in the biotechnology, pharmaceutical and food industries.	12-18-2008

Patent application number	Description	Published
20090137613	PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS - The present invention is concerned with new pharmaceutically acceptable salts of valacyclovir, polymorphic forms, processes for preparing the new pharmaceutically acceptable salts and new polymorphic forms, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.	05-28-2009